Industry Research Reports
Home > Reports > Service & Software > Global Biopharmaceutical Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Biopharmaceutical Testing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-10-23
Pages: 153 Pages
Report ld: 5218934
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Biopharmaceutical Testing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Biopharmaceutical Testing Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Eurofins Scientific
- SGS
- Envigo
- Exova Group
- PPD Inc.
- Pace Analytical Services
- Intertek Group
- DYNALABS
- RD Laboratories
- West Pharmaceutical Services
- Polymer Solutions
- Boston Analytical
- Accuratus Labs
- Microbac
- ARLBioPharma
- Lapuck Laboratories
- BioScreen
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Raw Materials Testing
- In-Process and Product Release Testing
- Finished Pharmaceutical Products Testing
- Environmental Samples
- Others
Segment by Application
- Hospitals
- Clinics
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Biopharmaceutical Testing Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Biopharmaceutical Testing Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biopharmaceutical Testing Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Raw Materials Testing
1.2.3 In-Process and Product Release Testing
1.2.4 Finished Pharmaceutical Products Testing
1.2.5 Environmental Samples
1.2.6 Others
1.3 Market Segmentation by Application
1.3.1 Global Biopharmaceutical Testing Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biopharmaceutical Testing Services Revenue Estimates and Forecasts 2020-2031
2.2 Global Biopharmaceutical Testing Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Biopharmaceutical Testing Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Biopharmaceutical Testing Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Raw Materials Testing Market Size by Players
3.3.2 In-Process and Product Release Testing Market Size by Players
3.3.3 Finished Pharmaceutical Products Testing Market Size by Players
3.3.4 Environmental Samples Market Size by Players
3.3.5 Others Market Size by Players
3.4 Global Biopharmaceutical Testing Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biopharmaceutical Testing Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biopharmaceutical Testing Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Biopharmaceutical Testing Services Market Size by Type (2020-2031)
6.4 North America Biopharmaceutical Testing Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biopharmaceutical Testing Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Biopharmaceutical Testing Services Market Size by Type (2020-2031)
7.4 Europe Biopharmaceutical Testing Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biopharmaceutical Testing Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Biopharmaceutical Testing Services Market Size by Type (2020-2031)
8.4 Asia-Pacific Biopharmaceutical Testing Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Biopharmaceutical Testing Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Biopharmaceutical Testing Services Market Size by Type (2020-2031)
9.4 Central and South America Biopharmaceutical Testing Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biopharmaceutical Testing Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Biopharmaceutical Testing Services Market Size by Type (2020-2031)
10.4 Middle East and Africa Biopharmaceutical Testing Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biopharmaceutical Testing Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Eurofins Scientific
11.1.1 Eurofins Scientific Corporation Information
11.1.2 Eurofins Scientific Business Overview
11.1.3 Eurofins Scientific Biopharmaceutical Testing Services Product Features and Attributes
11.1.4 Eurofins Scientific Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.1.5 Eurofins Scientific Biopharmaceutical Testing Services Revenue by Product in 2024
11.1.6 Eurofins Scientific Biopharmaceutical Testing Services Revenue by Application in 2024
11.1.7 Eurofins Scientific Biopharmaceutical Testing Services Revenue by Geographic Area in 2024
11.1.8 Eurofins Scientific Biopharmaceutical Testing Services SWOT Analysis
11.1.9 Eurofins Scientific Recent Developments
11.2 SGS
11.2.1 SGS Corporation Information
11.2.2 SGS Business Overview
11.2.3 SGS Biopharmaceutical Testing Services Product Features and Attributes
11.2.4 SGS Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.2.5 SGS Biopharmaceutical Testing Services Revenue by Product in 2024
11.2.6 SGS Biopharmaceutical Testing Services Revenue by Application in 2024
11.2.7 SGS Biopharmaceutical Testing Services Revenue by Geographic Area in 2024
11.2.8 SGS Biopharmaceutical Testing Services SWOT Analysis
11.2.9 SGS Recent Developments
11.3 Envigo
11.3.1 Envigo Corporation Information
11.3.2 Envigo Business Overview
11.3.3 Envigo Biopharmaceutical Testing Services Product Features and Attributes
11.3.4 Envigo Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.3.5 Envigo Biopharmaceutical Testing Services Revenue by Product in 2024
11.3.6 Envigo Biopharmaceutical Testing Services Revenue by Application in 2024
11.3.7 Envigo Biopharmaceutical Testing Services Revenue by Geographic Area in 2024
11.3.8 Envigo Biopharmaceutical Testing Services SWOT Analysis
11.3.9 Envigo Recent Developments
11.4 Exova Group
11.4.1 Exova Group Corporation Information
11.4.2 Exova Group Business Overview
11.4.3 Exova Group Biopharmaceutical Testing Services Product Features and Attributes
11.4.4 Exova Group Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.4.5 Exova Group Biopharmaceutical Testing Services Revenue by Product in 2024
11.4.6 Exova Group Biopharmaceutical Testing Services Revenue by Application in 2024
11.4.7 Exova Group Biopharmaceutical Testing Services Revenue by Geographic Area in 2024
11.4.8 Exova Group Biopharmaceutical Testing Services SWOT Analysis
11.4.9 Exova Group Recent Developments
11.5 PPD Inc.
11.5.1 PPD Inc. Corporation Information
11.5.2 PPD Inc. Business Overview
11.5.3 PPD Inc. Biopharmaceutical Testing Services Product Features and Attributes
11.5.4 PPD Inc. Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.5.5 PPD Inc. Biopharmaceutical Testing Services Revenue by Product in 2024
11.5.6 PPD Inc. Biopharmaceutical Testing Services Revenue by Application in 2024
11.5.7 PPD Inc. Biopharmaceutical Testing Services Revenue by Geographic Area in 2024
11.5.8 PPD Inc. Biopharmaceutical Testing Services SWOT Analysis
11.5.9 PPD Inc. Recent Developments
11.6 Pace Analytical Services
11.6.1 Pace Analytical Services Corporation Information
11.6.2 Pace Analytical Services Business Overview
11.6.3 Pace Analytical Services Biopharmaceutical Testing Services Product Features and Attributes
11.6.4 Pace Analytical Services Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.6.5 Pace Analytical Services Recent Developments
11.7 Intertek Group
11.7.1 Intertek Group Corporation Information
11.7.2 Intertek Group Business Overview
11.7.3 Intertek Group Biopharmaceutical Testing Services Product Features and Attributes
11.7.4 Intertek Group Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.7.5 Intertek Group Recent Developments
11.8 DYNALABS
11.8.1 DYNALABS Corporation Information
11.8.2 DYNALABS Business Overview
11.8.3 DYNALABS Biopharmaceutical Testing Services Product Features and Attributes
11.8.4 DYNALABS Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.8.5 DYNALABS Recent Developments
11.9 RD Laboratories
11.9.1 RD Laboratories Corporation Information
11.9.2 RD Laboratories Business Overview
11.9.3 RD Laboratories Biopharmaceutical Testing Services Product Features and Attributes
11.9.4 RD Laboratories Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.9.5 RD Laboratories Recent Developments
11.10 West Pharmaceutical Services
11.10.1 West Pharmaceutical Services Corporation Information
11.10.2 West Pharmaceutical Services Business Overview
11.10.3 West Pharmaceutical Services Biopharmaceutical Testing Services Product Features and Attributes
11.10.4 West Pharmaceutical Services Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Polymer Solutions
11.11.1 Polymer Solutions Corporation Information
11.11.2 Polymer Solutions Business Overview
11.11.3 Polymer Solutions Biopharmaceutical Testing Services Product Features and Attributes
11.11.4 Polymer Solutions Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.11.5 Polymer Solutions Recent Developments
11.12 Boston Analytical
11.12.1 Boston Analytical Corporation Information
11.12.2 Boston Analytical Business Overview
11.12.3 Boston Analytical Biopharmaceutical Testing Services Product Features and Attributes
11.12.4 Boston Analytical Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.12.5 Boston Analytical Recent Developments
11.13 Accuratus Labs
11.13.1 Accuratus Labs Corporation Information
11.13.2 Accuratus Labs Business Overview
11.13.3 Accuratus Labs Biopharmaceutical Testing Services Product Features and Attributes
11.13.4 Accuratus Labs Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.13.5 Accuratus Labs Recent Developments
11.14 Microbac
11.14.1 Microbac Corporation Information
11.14.2 Microbac Business Overview
11.14.3 Microbac Biopharmaceutical Testing Services Product Features and Attributes
11.14.4 Microbac Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.14.5 Microbac Recent Developments
11.15 ARLBioPharma
11.15.1 ARLBioPharma Corporation Information
11.15.2 ARLBioPharma Business Overview
11.15.3 ARLBioPharma Biopharmaceutical Testing Services Product Features and Attributes
11.15.4 ARLBioPharma Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.15.5 ARLBioPharma Recent Developments
11.16 Lapuck Laboratories
11.16.1 Lapuck Laboratories Corporation Information
11.16.2 Lapuck Laboratories Business Overview
11.16.3 Lapuck Laboratories Biopharmaceutical Testing Services Product Features and Attributes
11.16.4 Lapuck Laboratories Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.16.5 Lapuck Laboratories Recent Developments
11.17 BioScreen
11.17.1 BioScreen Corporation Information
11.17.2 BioScreen Business Overview
11.17.3 BioScreen Biopharmaceutical Testing Services Product Features and Attributes
11.17.4 BioScreen Biopharmaceutical Testing Services Revenue and Gross Margin (2020-2025)
11.17.5 BioScreen Recent Developments
12 Biopharmaceutical Testing ServicesIndustry Chain Analysis
12.1 Biopharmaceutical Testing Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biopharmaceutical Testing Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biopharmaceutical Testing Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Biopharmaceutical Testing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Biopharmaceutical Testing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Biopharmaceutical Testing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Biopharmaceutical Testing Services Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Biopharmaceutical Testing Services Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Biopharmaceutical Testing Services Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Biopharmaceutical Testing Services Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Biopharmaceutical Testing Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Testing Services as of 2024)
Table 11. Global Biopharmaceutical Testing Services Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Biopharmaceutical Testing Services Companies Headquarters
Table 13. Global Biopharmaceutical Testing Services Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Biopharmaceutical Testing Services Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Biopharmaceutical Testing Services Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Biopharmaceutical Testing Services Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Biopharmaceutical Testing Services Revenue by Application (2026-2031) & (US$ Million)
Table 21. Biopharmaceutical Testing Services High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Biopharmaceutical Testing Services Growth Accelerators and Market Barriers
Table 25. North America Biopharmaceutical Testing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Biopharmaceutical Testing Services Growth Accelerators and Market Barriers
Table 27. Europe Biopharmaceutical Testing Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Biopharmaceutical Testing Services Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Biopharmaceutical Testing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Biopharmaceutical Testing Services Investment Opportunities and Key Challenges
Table 31. Central and South America Biopharmaceutical Testing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Biopharmaceutical Testing Services Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Biopharmaceutical Testing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Eurofins Scientific Corporation Information
Table 35. Eurofins Scientific Description and Major Businesses
Table 36. Eurofins Scientific Product Features and Attributes
Table 37. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Eurofins Scientific Revenue Proportion by Product in 2024
Table 39. Eurofins Scientific Revenue Proportion by Application in 2024
Table 40. Eurofins Scientific Revenue Proportion by Geographic Area in 2024
Table 41. Eurofins Scientific Biopharmaceutical Testing Services SWOT Analysis
Table 42. Eurofins Scientific Recent Developments
Table 43. SGS Corporation Information
Table 44. SGS Description and Major Businesses
Table 45. SGS Product Features and Attributes
Table 46. SGS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. SGS Revenue Proportion by Product in 2024
Table 48. SGS Revenue Proportion by Application in 2024
Table 49. SGS Revenue Proportion by Geographic Area in 2024
Table 50. SGS Biopharmaceutical Testing Services SWOT Analysis
Table 51. SGS Recent Developments
Table 52. Envigo Corporation Information
Table 53. Envigo Description and Major Businesses
Table 54. Envigo Product Features and Attributes
Table 55. Envigo Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Envigo Revenue Proportion by Product in 2024
Table 57. Envigo Revenue Proportion by Application in 2024
Table 58. Envigo Revenue Proportion by Geographic Area in 2024
Table 59. Envigo Biopharmaceutical Testing Services SWOT Analysis
Table 60. Envigo Recent Developments
Table 61. Exova Group Corporation Information
Table 62. Exova Group Description and Major Businesses
Table 63. Exova Group Product Features and Attributes
Table 64. Exova Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Exova Group Revenue Proportion by Product in 2024
Table 66. Exova Group Revenue Proportion by Application in 2024
Table 67. Exova Group Revenue Proportion by Geographic Area in 2024
Table 68. Exova Group Biopharmaceutical Testing Services SWOT Analysis
Table 69. Exova Group Recent Developments
Table 70. PPD Inc. Corporation Information
Table 71. PPD Inc. Description and Major Businesses
Table 72. PPD Inc. Product Features and Attributes
Table 73. PPD Inc. Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. PPD Inc. Revenue Proportion by Product in 2024
Table 75. PPD Inc. Revenue Proportion by Application in 2024
Table 76. PPD Inc. Revenue Proportion by Geographic Area in 2024
Table 77. PPD Inc. Biopharmaceutical Testing Services SWOT Analysis
Table 78. PPD Inc. Recent Developments
Table 79. Pace Analytical Services Corporation Information
Table 80. Pace Analytical Services Description and Major Businesses
Table 81. Pace Analytical Services Product Features and Attributes
Table 82. Pace Analytical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Pace Analytical Services Recent Developments
Table 84. Intertek Group Corporation Information
Table 85. Intertek Group Description and Major Businesses
Table 86. Intertek Group Product Features and Attributes
Table 87. Intertek Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Intertek Group Recent Developments
Table 89. DYNALABS Corporation Information
Table 90. DYNALABS Description and Major Businesses
Table 91. DYNALABS Product Features and Attributes
Table 92. DYNALABS Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. DYNALABS Recent Developments
Table 94. RD Laboratories Corporation Information
Table 95. RD Laboratories Description and Major Businesses
Table 96. RD Laboratories Product Features and Attributes
Table 97. RD Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. RD Laboratories Recent Developments
Table 99. West Pharmaceutical Services Corporation Information
Table 100. West Pharmaceutical Services Description and Major Businesses
Table 101. West Pharmaceutical Services Product Features and Attributes
Table 102. West Pharmaceutical Services Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. West Pharmaceutical Services Recent Developments
Table 104. Polymer Solutions Corporation Information
Table 105. Polymer Solutions Description and Major Businesses
Table 106. Polymer Solutions Product Features and Attributes
Table 107. Polymer Solutions Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. Polymer Solutions Recent Developments
Table 109. Boston Analytical Corporation Information
Table 110. Boston Analytical Description and Major Businesses
Table 111. Boston Analytical Product Features and Attributes
Table 112. Boston Analytical Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. Boston Analytical Recent Developments
Table 114. Accuratus Labs Corporation Information
Table 115. Accuratus Labs Description and Major Businesses
Table 116. Accuratus Labs Product Features and Attributes
Table 117. Accuratus Labs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 118. Accuratus Labs Recent Developments
Table 119. Microbac Corporation Information
Table 120. Microbac Description and Major Businesses
Table 121. Microbac Product Features and Attributes
Table 122. Microbac Revenue (US$ Million) and Gross Margin (2020-2025)
Table 123. Microbac Recent Developments
Table 124. ARLBioPharma Corporation Information
Table 125. ARLBioPharma Description and Major Businesses
Table 126. ARLBioPharma Product Features and Attributes
Table 127. ARLBioPharma Revenue (US$ Million) and Gross Margin (2020-2025)
Table 128. ARLBioPharma Recent Developments
Table 129. Lapuck Laboratories Corporation Information
Table 130. Lapuck Laboratories Description and Major Businesses
Table 131. Lapuck Laboratories Product Features and Attributes
Table 132. Lapuck Laboratories Revenue (US$ Million) and Gross Margin (2020-2025)
Table 133. Lapuck Laboratories Recent Developments
Table 134. BioScreen Corporation Information
Table 135. BioScreen Description and Major Businesses
Table 136. BioScreen Product Features and Attributes
Table 137. BioScreen Revenue (US$ Million) and Gross Margin (2020-2025)
Table 138. BioScreen Recent Developments
Table 139. Raw Materials Key Suppliers
Table 140. Distributors List
Table 141. Market Trends and Market Evolution
Table 142. Market Drivers and Opportunities
Table 143. Market Challenges, Risks, and Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Biopharmaceutical Testing Services Product Picture
Figure 2. Global Biopharmaceutical Testing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Raw Materials Testing Product Picture
Figure 4. In-Process and Product Release Testing Product Picture
Figure 5. Finished Pharmaceutical Products Testing Product Picture
Figure 6. Environmental Samples Product Picture
Figure 7. Others Product Picture
Figure 8. Global Biopharmaceutical Testing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Biopharmaceutical Testing Services Report Years Considered
Figure 13. Global Biopharmaceutical Testing Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 15. Global Biopharmaceutical Testing Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Biopharmaceutical Testing Services Revenue Market Share by Region (2020-2031)
Figure 17. Global Biopharmaceutical Testing Services Revenue Market Share Ranking (2024)
Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 19. Raw Materials Testing Revenue Market Share by Player in 2024
Figure 20. In-Process and Product Release Testing Revenue Market Share by Player in 2024
Figure 21. Finished Pharmaceutical Products Testing Revenue Market Share by Player in 2024
Figure 22. Environmental Samples Revenue Market Share by Player in 2024
Figure 23. Others Revenue Market Share by Player in 2024
Figure 24. Global Biopharmaceutical Testing Services Revenue Market Share by Type (2020-2031)
Figure 25. Global Biopharmaceutical Testing Services Revenue Market Share by Application (2020-2031)
Figure 26. North America Biopharmaceutical Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 27. North America Top 5 Players Biopharmaceutical Testing Services Revenue (US$ Million) in 2024
Figure 28. North America Biopharmaceutical Testing Services Revenue (US$ Million) by Type (2020 - 2031)
Figure 29. North America Biopharmaceutical Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 30. US Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 31. Canada Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 32. Mexico Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 33. Europe Biopharmaceutical Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 34. Europe Top 5 Players Biopharmaceutical Testing Services Revenue (US$ Million) in 2024
Figure 35. Europe Biopharmaceutical Testing Services Revenue (US$ Million) by Type (2020-2031)
Figure 36. Europe Biopharmaceutical Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 37. Germany Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 38. France Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 39. U.K. Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 40. Italy Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 41. Russia Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 42. Asia-Pacific Biopharmaceutical Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Asia-Pacific Top 8 Players Biopharmaceutical Testing Services Revenue (US$ Million) in 2024
Figure 44. Asia-Pacific Biopharmaceutical Testing Services Revenue (US$ Million) by Type (2020-2031)
Figure 45. Asia-Pacific Biopharmaceutical Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 46. Indonesia Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 47. Japan Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 48. South Korea Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 49. Australia Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 50. India Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 51. Indonesia Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 52. Vietnam Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 53. Malaysia Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 54. Philippines Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 55. Singapore Biopharmaceutical Testing Services Revenue (2020-2031) & (US$ Million)
Figure 56. Central and South America Biopharmaceutical Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Central and South America Top 5 Players Biopharmaceutical Testing Services Revenue (US$ Million) in 2024
Figure 58. Central and South America Biopharmaceutical Testing Services Revenue (US$ Million) by Type (2020-2031)
Figure 59. Central and South America Biopharmaceutical Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 60. Brazil Biopharmaceutical Testing Services Revenue (2020-2025) & (US$ Million)
Figure 61. Argentina Biopharmaceutical Testing Services Revenue (2020-2025) & (US$ Million)
Figure 62. Middle East and Africa Biopharmaceutical Testing Services Revenue YoY (2020-2031) & (US$ Million)
Figure 63. Middle East and Africa Top 5 Players Biopharmaceutical Testing Services Revenue (US$ Million) in 2024
Figure 64. South America Biopharmaceutical Testing Services Revenue (US$ Million) by Type (2020-2031)
Figure 65. Middle East and Africa Biopharmaceutical Testing Services Revenue (US$ Million) by Application (2020-2031)
Figure 66. GCC Countries Biopharmaceutical Testing Services Revenue (2020-2025) & (US$ Million)
Figure 67. Israel Biopharmaceutical Testing Services Revenue (2020-2025) & (US$ Million)
Figure 68. Egypt Biopharmaceutical Testing Services Revenue (2020-2025) & (US$ Million)
Figure 69. South Africa Biopharmaceutical Testing Services Revenue (2020-2025) & (US$ Million)
Figure 70. Biopharmaceutical Testing Services Industry Chain Mapping
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Biopharmaceutical Testing Services market?
The top companies in the global Biopharmaceutical Testing Services market are Eurofins Scientific、SGS、Envigo.
Related Reports
Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 121
USD 3950.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2026
The global Biopharmaceutical Testing Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 134
USD 2900.00
(Single User License)
Global Biopharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biopharmaceutical Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 101
USD 4250.00
(Single User License)
Biopharmaceutical Testing Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 139
USD 3950.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2025
The global market for Biopharmaceutical Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 95
USD 2900.00
(Single User License)
Global Biopharmaceutical Testing Services Market Insights, Forecast to 2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-04-19
Pages: 113
USD 4900.00
(Single User License)
Global Biopharmaceutical Testing Services Market Research Report 2024
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-01-17
Pages: 90
USD 2900.00
(Single User License)
Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published Date: 2024-01-06
Pages: 131
USD 3950.00
(Single User License)
Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 121
USD 3950.00 (Single User License)Global Biopharmaceutical Testing Services Market Research Report 2026
The global Biopharmaceutical Testing Services market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 134
USD 2900.00 (Single User License)Global Biopharmaceutical Testing Services Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biopharmaceutical Testing Services market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 101
USD 4250.00 (Single User License)Biopharmaceutical Testing Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biopharmaceutical Testing Services was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 139
USD 3950.00 (Single User License)Global Biopharmaceutical Testing Services Market Research Report 2025
The global market for Biopharmaceutical Testing Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 95
USD 2900.00 (Single User License)Global Biopharmaceutical Testing Services Market Insights, Forecast to 2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-04-19
Pages: 113
USD 4900.00 (Single User License)Global Biopharmaceutical Testing Services Market Research Report 2024
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-01-17
Pages: 90
USD 2900.00 (Single User License)Biopharmaceutical Testing Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Biopharmaceutical testing is a critical step in the development of a biosimilar. Analytical testing provides the information needed to produce a safe and effective biopharmaceutical product, and the efficacy or safety depends on a product’s critical quality attributes (CQA). Biopharmaceutical testing involves the development, validation, and execution of wide-ranging cGMP analytical strategies, from routine tests to the application of state-of-the-art instrumental analysis, such as mass spectrometry.
Published: 2024-01-06
Pages: 131
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now